A M Abdel-Aziz - JoVE Visualize

Showing results (81-90 of 128) with videos related to

Pageof 13

Sort By:

Bioorganic & Medicinal Chemistry|June 27, 2016

Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studiesAlaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.

European Journal of Medicinal Chemistry|June 19, 2016

Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinonesAlaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.

Journal of Enzyme Inhibition and Medicinal Chemistry|December 19, 2017

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking studyMagda A-A El-Sayed, Walaa M El-Husseiny, Naglaa I Abdel-Aziz, et al.

European Journal of Medicinal Chemistry|September 15, 2018

Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular dockingWalaa M El-Husseiny, Magda A-A El-Sayed, Naglaa I Abdel-Aziz, et al.

Pharmaceuticals (Basel, Switzerland)|April 26, 2025

Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff's Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition ActivitiesFhdah S Alanazi, Hamad M Alkahtani, Alaa A-M Abdel-Aziz, et al.

RSC Advances|January 7, 2025

Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profileAdel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit, et al.

Bioorganic Chemistry|November 4, 2020

Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysisAdel S El-Azab, Alaa A-M Abdel-Aziz, Nawaf A AlSaif, et al.

Archiv Der Pharmazie|January 25, 2008

Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124)Adnan A Kadi, Hassan A El-Kashef, Alaa A-M Abdel-Aziz, et al.

European Journal of Medicinal Chemistry|January 1, 2015

Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activitiesAmer M Alanazi, Adel S El-Azab, Ibrahim A Al-Suwaidan, et al.

Journal of Enzyme Inhibition and Medicinal Chemistry|July 19, 2017

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studiesAdel S El-Azab, Abdullah Al-Dhfyan, Alaa A-M Abdel-Aziz, et al.

Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:

Pageof 13

Bioorganic & Medicinal Chemistry|June 27, 2016

Design, synthesis of 2,3-disubstitued 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents: COX-1/2 inhibitory activities and molecular docking studiesAlaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.

European Journal of Medicinal Chemistry|June 19, 2016

Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinonesAlaa A-M Abdel-Aziz, Laila A Abou-Zeid, Kamal Eldin H ElTahir, et al.

Journal of Enzyme Inhibition and Medicinal Chemistry|December 19, 2017

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking studyMagda A-A El-Sayed, Walaa M El-Husseiny, Naglaa I Abdel-Aziz, et al.

European Journal of Medicinal Chemistry|September 15, 2018

Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular dockingWalaa M El-Husseiny, Magda A-A El-Sayed, Naglaa I Abdel-Aziz, et al.

Pharmaceuticals (Basel, Switzerland)|April 26, 2025

Synthesis, Antitumor Activities, and Apoptosis-Inducing Activities of Schiff's Bases Incorporating Imidazolidine-2,4-dione Scaffold: Molecular Docking Studies and Enzymatic Inhibition ActivitiesFhdah S Alanazi, Hamad M Alkahtani, Alaa A-M Abdel-Aziz, et al.

RSC Advances|January 7, 2025

Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profileAdel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit, et al.

Bioorganic Chemistry|November 4, 2020

Antitumor activity, multitarget mechanisms, and molecular docking studies of quinazoline derivatives based on a benzenesulfonamide scaffold: Cell cycle analysisAdel S El-Azab, Alaa A-M Abdel-Aziz, Nawaf A AlSaif, et al.

Archiv Der Pharmazie|January 25, 2008

Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124)Adnan A Kadi, Hassan A El-Kashef, Alaa A-M Abdel-Aziz, et al.

European Journal of Medicinal Chemistry|January 1, 2015

Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activitiesAmer M Alanazi, Adel S El-Azab, Ibrahim A Al-Suwaidan, et al.

Journal of Enzyme Inhibition and Medicinal Chemistry|July 19, 2017

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studiesAdel S El-Azab, Abdullah Al-Dhfyan, Alaa A-M Abdel-Aziz, et al.

Pageof 13